文档介绍：脑利钠肽临床应用的研究进展
[1] Sudoh T, Kangawa K, MinaminoN, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988,332(10):78-86
[2] Marc V, Jozef B, Marc G.. Brain and other natriuretic peptides: molecular aspects[J]. Eur J Heart Failure, :261-268
[3] Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors[J]. Circulation, 1992,86(4):1081-1088
[4] ,Choy AM, Struthers AD. Atrial and brain natriuretic peptides:a dual natriuretic peptide system potentially involved in circulatiory homeostasis[J]. Clin Sci(Lond),1992,83(5):519-520
[5] Soleilhac JM, Lucas E, Beaumont A et al. A94-kDa protein, identified as neutral endopeptiidase-, can in activate atrlal natriuretic peptide in the vascular endothelium[J]. Mol pharmacol, 1992,41(4):609-614
[6] i WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide in the treatment of pensateed congestive heart failure[J]. NEngl J Med,200,343:246-253
[7] Yancy CW, Saltzberg MT, Berkowitz RL, et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting(from the FUSIONI Trial) [J]. Am J Cardiol, 2004,94:595-601
[8] Aroson D, Burger AJ. ous nesiritide(human B-type natriuretic peptide) reduces plasrna endothelin-1 levels in patients with sated congestive heart failure[J]. Am J Cardiol,2002,90:435-438
[9] Hans K, Mery B. B-type natriuretic peptide(BNP)and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device[J]. Clin chen, 2004,50(9):1670-1672
[10] Burger AJ. Areview of the renal renal and neruohormonal effects of B-type natriuretic peptide[J]. Congest Heart Fail, 2005,11(1):30
[11] Cataliotti A, Boerrigter G Costello-Boerrigter LC, et al. Brain natriureetic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure[J]. Circulation,2004,109:
[12] Andrew D, Michaels MD, Andrew Klein